Synergistic Binding of SARS-CoV-2 to ACE2 and Gangliosides in Native Lipid Membranes

ACS Infect Dis. 2024 Mar 8;10(3):907-916. doi: 10.1021/acsinfecdis.3c00519. Epub 2024 Feb 27.

Abstract

Viruses utilize cell surface glycans and plasma membrane receptors to attain an adequate attachment strength for initiating cellular entry. We show that SARS-CoV-2 particles bind to endogenous ACE2 receptors and added sialylated gangliosides in near-native membranes. This was explored using supported membrane bilayers (SMBs) that were formed using plasma membrane vesicles having endogenous ACE2 and GD1a gangliosides reconstituted in lipid vesicles. The virus binding rate to the SMBs is influenced by GD1a and inhibition of the ganglioside reduces the extent of virus binding to the membrane receptors. Using combinations of inhibition assays, we confirm that added GD1a in lipid membranes increases the availability of the endogenous ACE2 receptor and results in the synergistic binding of SARS-CoV-2 to the membrane receptors in SMBs.

Keywords: ACE2; SARS-CoV-2; fluorescence imaging; gangliosides; membrane attachment; synergistic binding.

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • COVID-19*
  • Cell Membrane / metabolism
  • Gangliosides
  • Humans
  • SARS-CoV-2* / metabolism

Substances

  • Angiotensin-Converting Enzyme 2
  • Gangliosides